Epitalon: Compound Profile

Epitalon sits in the small family of short "peptide bioregulators" that Russian gerontology groups first described, where a handful of amino acids is proposed to touch gene-expression programs rather than a single receptor. This profile covers what the peptide is, the telomerase and transcriptional activity the literature attributes to it, and how it is handled in the laboratory. The framing throughout is preclinical: cell cultures and animal models, not people.

What is Epitalon?#

Epitalon is a synthetic linear tetrapeptide built from four residues: alanine, glutamic acid, aspartic acid, and glycine, written Ala-Glu-Asp-Gly and abbreviated AEDG. It was developed as a synthetic counterpart to Epithalamin, a peptide preparation originally extracted from the pineal gland, which is why the research literature often describes it as a pineal or bioregulator peptide. Because the molecule is so short, its identity is unusually clean to pin down: a single defined sequence, one molecular formula, and a registered chemical record, listed below.

What does the research literature study?#

The most-cited thread in the Epitalon literature is telomere biology. Cell-line work has reported that exposure to the AEDG peptide is associated with increased telomerase activity and telomere elongation, with the effect attributed either to upregulation of the telomerase enzyme or to an alternative lengthening mechanism (Ph.D.-level cell-line study, PMID 40908429). A recent structured overview, PMID 40141333 collates the reported activities and repeatedly flags how much of the evidence base is preclinical and mechanistic rather than clinical.

A second thread treats Epitalon as a transcriptional actor. A neurogenesis gene-expression study, PMID 32019204 reported that the AEDG peptide altered gene expression and protein synthesis in cell models, proposing an epigenetic mechanism rather than a classic receptor-binding one. Related monocyte/macrophage cell-line work, PMID 35408963 placed short bioregulator peptides against proliferative and inflammatory signaling readouts, and an in-vitro oxidative-stress model, PMID 40493162 examined the peptide framed as an antioxidant tetrapeptide. Across these, the recurring theme is a small peptide studied for how it shifts gene-expression and stress-response pathways in culture, which is exactly why it recurs in cellular-senescence and aging-model reviews such as PMID 33682799. None of this work demonstrates outcomes in humans.

Where Epitalon sits among bioregulator peptides#

Most catalog peptides are studied as agonists of a named receptor. Epitalon is a contrast case: the AEDG sequence is short enough that the literature proposes it works upstream, at the level of gene expression, which is what makes the "bioregulator" label stick. That places it apart from the signaling-peptide profiles Nexara tracks elsewhere and closer to compounds studied for cellular-aging endpoints. Nexara stocks Epitalon as a single-compound research peptide rather than as part of a multi-peptide blend, reflecting how it is investigated in the literature: on its own, against telomerase and gene-expression readouts.

Handling and storage#

Epitalon is supplied as a white lyophilized powder and dissolved prior to use. As a short, highly polar tetrapeptide it is handled the same way as the rest of the catalog: the reconstitution primer covers solvent selection and avoiding aggregation, while the cold-chain article covers how stability changes once the powder is in solution. The lyophilized form is best kept cold and protected from light, with freeze-thaw cycles minimized once reconstituted.

Sources and further reading#

• Overview of Epitalon — highly bioactive pineal tetrapeptide with promising properties (PMID 40141333): a structured overview collating the reported activities of the AEDG peptide across the preclinical literature. International Journal of Molecular Sciences 2025.
• Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity (PMID 40908429): a cell-line study of the reported telomerase and telomere-length mechanism. Biogerontology 2025.
• AEDG peptide (Epitalon) stimulates gene expression and protein synthesis during neurogenesis: possible epigenetic mechanism (PMID 32019204): a gene-expression study proposing an epigenetic rather than receptor mechanism. Molecules 2020.
• Peptides regulating proliferative activity and inflammatory pathways in the monocyte/macrophage THP-1 cell line (PMID 35408963): cell-line work placing short bioregulator peptides against proliferative and inflammatory readouts. International Journal of Molecular Sciences 2022.
• The antioxidant tetrapeptide Epitalon in an in-vitro model (PMID 40493162): an in-vitro study framing Epitalon around antioxidant and oxidative-stress pathways. Stem Cell Reviews and Reports 2025.
• Aging delay: of mice and men (PMID 33682799): a review of cellular-aging models that situates peptide bioregulators such as Epitalon in the broader senescence literature. Acta Biomedica 2021.
• Epitalon, PubChem CID 219042: chemical identity record for the AEDG tetrapeptide (molecular formula, weight, and structure).